Forward Pharma A/S (FWP)
NASDAQ: FWP
· Real-Time Price · USD
1.95
0.00 (0.00%)
At close: Dec 27, 2022, 10:00 PM
Company Description
Forward Pharma A/S does not have significant operations.
Previously, it operated as a biopharmaceutical company that focused on developing FP187 proprietary formulation of dimethyl fumarate for the treatment of inflammatory and neurological indications.
Forward Pharma A/S was incorporated in 2005 and is headquartered in Copenhagen, Denmark.
Forward Pharma A/S
| Country | DK |
| IPO Date | Oct 15, 2014 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 4 |
| CEO | Claus Svendsen |
Contact Details
Address: Oestergade 24A, 1, Copenhagen K Koebenhavn K, DK | |
| Website | https://www.forward-pharma.com |
Stock Details
| Ticker Symbol | FWP |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001604924 |
| CUSIP Number | 34986J105 |
| ISIN Number | US34986J2042 |
| Employer ID | 00-0000000 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Dr. Claus Bo Søndergaard Svendsen M.D., Ph.D. | Chief Executive Officer |
| Florian Schonharting M.Sc. (Econ) | Co-Founder & Chairman |
| Thomas Carbone | Vice President of Fin. & Controller |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Feb 14, 2023 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Jan 20, 2023 | POS AM | Filing |
| Jan 20, 2023 | S-8 POS | Filing |
| Jan 20, 2023 | S-8 POS | Filing |
| Jan 17, 2023 | 15-12G | Filing |
| Jan 13, 2023 | 6-K | Filing |
| Jan 06, 2023 | 25-NSE | Filing |
| Dec 29, 2022 | SC 13G | Statement of acquisition of beneficial ownership b... |
| Dec 28, 2022 | 6-K | Filing |
| Dec 19, 2022 | 6-K | Filing |